SEBI's Derivative Review: Why Unlisted Valuation Matters

SEBI's Derivative Review: A Window into Valuation Realities

SEBI's recent announcement about reviewing the derivative settlement price methodology, especially after the T+0 settlement and the Corporate Action Service (CAS) rollout, might seem like something only for active F&O traders. But for those of us tracking the private markets – unlisted shares, pre-IPO deals, even global private equity – it's a telling signal. Why? Because at its core, this review is about how prices are determined and how risk is managed when real-time, liquid market data might be imperfect or absent. And that, right there, is the crux of unlisted shares and pre-IPO investing: getting the unlisted share valuation right.

When the market regulator steps in to fine-tune how even publicly traded derivatives are settled, it underscores the inherent challenges in price discovery, especially when corporate actions (like dividends, splits, mergers) complicate matters. Now, imagine applying that complexity to a company that doesn't trade daily on an exchange, whose financials might be less transparent, and whose future is still being written. That's the world of unlisted shares, and it's why understanding valuation isn't just an academic exercise – it's your primary defence.

Why SEBI's Move Resonates with Private Investors

Think about it: derivative contracts rely on an underlying asset's price. If that underlying price can be skewed or if corporate actions aren't factored in seamlessly, the derivative's settlement can go awry. SEBI wants to ensure fairness and accuracy.

In the private markets, there's no daily closing price to lean on. Your "underlying asset" is an unlisted company, and its value isn't determined by bid-ask spreads but by a mix of financial models, comparable transactions, and future projections. The regulator's focus on robust methodologies for even liquid assets should serve as a wake-up call for private market investors: if it's tricky for listed entities, it's exponentially more critical for unlisted ones.

The Core Challenge: Unlisted Share Valuation

Unlike listed companies where market forces provide a daily, objective price, unlisted share valuation is inherently more subjective. It’s a blend of art and science, requiring a deep dive into the company's fundamentals, sector dynamics, and macroeconomic outlook.

Key Factors Influencing Unlisted Share Valuation

1. Financial Health & Growth Trajectory: This is non-negotiable. Revenue growth, profitability (or clear path to it), cash flow, and balance sheet strength are primary drivers. For a high-growth startup, revenue multiples might be more relevant than immediate profits.
2. Sector & Market Opportunity: Is the company operating in a sunrise sector with massive tailwinds (e.g., AI, renewable energy, specific SaaS niches)? What's the total addressable market (TAM), and how much of it can the company capture?
3. Management Team & Governance: Experience, track record, vision, and integrity of the leadership team are crucial. In private companies, you're not just investing in a business, but in the people building it.
4. Competitive Landscape: Who are the competitors? What's the company's moat – its sustainable competitive advantage? This could be technology, brand, network effects, or proprietary data.
5. Exit Potential: How will you eventually monetise your investment? Is there a clear path to an IPO, an acquisition by a larger player, or a secondary sale? The likelihood and timeframe of an exit significantly influence current valuation.
6. Liquidity Discount: This is a big one. Unlisted shares are illiquid. You can't just sell them on an exchange. This lack of liquidity typically warrants a discount compared to comparable listed companies. The size of this discount depends on the stage of the company, its maturity, and the perceived ease of future exit.

Common Valuation Methodologies for Private Companies

While there's no single "right" way, here are the dominant approaches:

• Discounted Cash Flow (DCF): This fundamental method projects a company's future cash flows and discounts them back to the present day using a suitable discount rate (often the Weighted Average Cost of Capital - WACC). It's robust but highly sensitive to assumptions about future growth and discount rates.
• Comparable Company Analysis (CCA) / Multiples Valuation: This involves identifying publicly traded companies similar to the unlisted target and applying their valuation multiples (e.g., Enterprise Value/Revenue, P/E, EV/EBITDA) to the unlisted company's financials. The challenge is finding truly comparable listed peers. A 20-30% discount for illiquidity is often applied to these multiples for unlisted firms.
• Precedent Transactions Analysis: Looking at recent M&A deals involving similar companies can provide insights into what buyers are willing to pay. Again, finding truly comparable transactions with disclosed values can be tough.
• Venture Capital Method (for early-stage): This works backward from a target exit valuation (e.g., at IPO or acquisition) and discounts it to the present, accounting for dilution and required rate of return. It's more about "what will this be worth then" than "what is it worth now."

Let’s take an example. Say you're looking at a SaaS company with ₹50 crore in annual recurring revenue (ARR) and growing at 40% year-on-year. If comparable listed SaaS companies trade at 10x EV/Revenue, you might start there. So, ₹50 crore ARR * 10 = ₹500 crore enterprise value. But then you'd apply a liquidity discount, perhaps 25%, bringing the valuation down to ₹375 crore. This is a simplified view, of course, but illustrates the process.

The Pitfalls: What to Watch Out For

• Over-reliance on projections: Founders are optimists. Their projections are often aggressive. Always stress-test these.
• Lack of transparency: Unlisted companies aren't subject to the same disclosure norms as listed ones. You need to do your due diligence thoroughly.
• "FOMO" valuations: The fear of missing out can drive valuations to unsustainable levels, especially in hot sectors. Stick to your own analysis.
• Dilution risk: Especially in early-stage companies, future funding rounds will dilute your ownership percentage. Factor this into your expected returns.

Beyond India: Global Private Markets and Valuation

The principles of global investing in private companies, whether through direct investments or feeder funds, remain largely the same. However, the context shifts:

• Market Maturity: Developed markets might have more mature private equity ecosystems, potentially offering more data points for comparable transactions.
• Regulatory Frameworks: Different jurisdictions have varying disclosure norms and investor protections.
• Currency Risk: If investing in a foreign currency, you're exposed to exchange rate fluctuations.
• Exit Avenues: IPO markets and M&A landscapes differ across countries.

Regardless of geography, a disciplined approach to unlisted share valuation is your bedrock. If SEBI is scrutinising derivative settlement on listed shares, it's a potent reminder that valuation is never straightforward, and always requires robust analysis.

Neoma Capital helps HNIs and family offices navigate these complexities, providing detailed valuation insights and due diligence for private market opportunities. If you're considering an investment in unlisted shares or a pre-IPO deal, understanding the true value is paramount.

Reach out to Neoma Capital for a deeper discussion on specific unlisted share opportunities or to understand how to apply robust valuation frameworks to your private investments. Book a call with our advisors today.

This is educational content, not investment advice. Investments in securities are subject to market risks.

Frequently Asked Questions

What makes unlisted share valuation different from listed share valuation?

Unlisted share valuation lacks the daily, objective market price discovery of listed shares. It relies on financial modeling, comparable company analysis, and precedent transactions, often incorporating a liquidity discount due to restricted tradability.

How does SEBI's derivative review relate to unlisted shares?

SEBI's review highlights the complexities of accurate price determination and risk management, even for liquid listed assets. This underscores the even greater challenge and importance of meticulous valuation for illiquid unlisted shares, where market data is scarce.

What are the biggest risks in valuing an unlisted company?

Key risks include over-reliance on aggressive future projections, limited financial transparency compared to public companies, emotional "FOMO" valuations, and the inherent illiquidity, which often requires a significant discount.

Can I use the same valuation methods for early-stage startups and mature unlisted companies?

While some methods like DCF can be adapted, early-stage startups often require approaches like the Venture Capital Method due to their lack of consistent cash flow and high growth potential. More mature unlisted companies might lean more on DCF and Comparable Company Analysis, similar to listed firms but with liquidity adjustments.